BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14992891)

  • 1. Influence of IFN-gamma polymorphism on the development of coronary vasculopathy after cardiac transplantation.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    Ann Thorac Surg; 2004 Mar; 77(3):875-80. PubMed ID: 14992891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of interleukin-10 polymorphism on the development of coronary vasculopathy following cardiac transplantation.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    Transpl Immunol; 2003; 11(2):223-8. PubMed ID: 12799207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?
    Densem CG; Ray M; Hutchinson IV; Yonan N; Brooks NH
    J Heart Lung Transplant; 2005 May; 24(5):559-65. PubMed ID: 15896753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
    Tambur AR; Pamboukian S; Costanzo MR; Heroux A
    J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-gamma in relation to acute rejection and graft vascular disease after clinical heart transplantation.
    Holweg CT; Peeters AM; Balk AH; Uitterlinden AG; Niesters HG; Maat AP; Weimar W; Baan CC
    Transpl Immunol; 2003; 11(1):121-7. PubMed ID: 12727483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between interferon-γ gene polymorphism and acute kidney allograft rejection.
    Zibar L; Wagner J; Pavlinić D; Galić J; Pasini J; Juras K; Barbić J
    Scand J Immunol; 2011 Apr; 73(4):319-24. PubMed ID: 21204904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.
    Haji SA; Starling RC; Avery RK; Mawhorter S; Tuzcu EM; Schoenhagen P; Cook DJ; Ratliff NB; McCarthy PM; Young JB; Yamani MH
    J Heart Lung Transplant; 2004 Mar; 23(3):277-83. PubMed ID: 15019636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    J Heart Lung Transplant; 2001 Dec; 20(12):1265-73. PubMed ID: 11744409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal allograft immune response is influenced by patient and donor cytokine genotypes.
    Canossi A; Piazza A; Poggi E; Ozzella G; Di Rocco M; Papola F; Iaria G; Adorno D
    Transplant Proc; 2007; 39(6):1805-12. PubMed ID: 17692619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of recipient cytokine gene polymorphism on cardiac transplantation outcome.
    Gourley IS; Denofrio D; Rand W; Desai S; Loh E; Kamoun M
    Hum Immunol; 2004 Mar; 65(3):248-54. PubMed ID: 15041164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation.
    Mlynarczewska A; Wysoczanska B; Karabon L; Bogunia-Kubik K; Lange A
    Bone Marrow Transplant; 2004 Aug; 34(4):339-44. PubMed ID: 15235581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients.
    Biolo G; Amoroso A; Savoldi S; Bosutti A; Martone M; Pirulli D; Bianco F; Ulivi S; Bertok S; Artero M; Barazzoni R; Zanetti M; Grassi G; Guarnieri G; Panzetta G
    Nephrol Dial Transplant; 2006 May; 21(5):1317-22. PubMed ID: 16410273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
    Lietz K; John R; Mancini DM; Edwards NM
    J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
    Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
    Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine gene polymorphisms in renal transplant recipients.
    Azarpira N; Aghdaie MH; Geramizadeh B; Behzadi S; Nikeghbalian S; Sagheb F; Rahsaz M; Behzad-Behbahanie A; Ayatollahi M; Darai M; Azarpira MR; Banihashemie M; Tabei SZ
    Exp Clin Transplant; 2006 Dec; 4(2):528-31. PubMed ID: 17238853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
    Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
    Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
    J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    Transpl Immunol; 2004 Nov; 13(3):211-7. PubMed ID: 15381204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.